MarketPulse

retinal ganglion cells

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Institute Of Molecular And Clinical Ophthalmology Basel (Iob)

Scientists Develop MitoCatch: Engineered Protein Tech to Deliver Healthy Mitochondria to Damaged Cells

IOB scientists unveil MitoCatch, engineered technology delivering healthy mitochondria to damaged cells. Early data shows improved cell survival in disease models.
NVSheart failureneurodegenerative diseases
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Oculis to Showcase Optic Neuritis Data as Privosegtor Advances to Pivotal Trials

Oculis presents Phase 2 ACUITY trial results for Privosegtor at neuro-ophthalmology conference, showing vision improvements. Breakthrough therapy advances to registrational PIONEER program.
OCSOCSAWPrivosegtoroptic neuritis